XG Sciences
Graphene nanoplatelet manufacturer supplying advanced materials for coatings, inks, batteries, and graphene-enhanced 3D printing filament.
- CEO / Founder
- Robert M. Blinstrub
- Team Size
- 11-50
- Stage
- Acquired
- Total Funding
- $1.8M
- Latest Round
- Seed
- Key Investors
- Hanwha Chemical; POSCO; Dow Chemical; Great Oaks Venture Capital; Michigan Pre-Seed Fund
Technology & Products
Key Products
xGnP® graphene nanoplatelets; XG Leaf® graphene sheets; Graphene-enhanced 3D printing filament; Conductive inks and coatings; Battery anode materials
Technological Advantage
Proprietary xGnP technology and patent portfolio; strong R&D capabilities; strategic partnerships with major industrial players.
Differentiation
Value Proposition
Provides graphene-enhanced materials that improve mechanical properties, thermal conductivity, and printability for 3D printing applications.
How They Differentiate
Focus on high-quality graphene nanoplatelets with proprietary production process; strong partnerships in automotive and energy sectors.
Market & Competition
Target Customers
Industrial manufacturers in automotive, energy, composites, and 3D printing
Industry Verticals
Automotive; Energy storage; Composites; 3D printing; Coatings and inks
Competitors
NanoXplore; Graphenea; Haydale Graphene Industries; Graphene 3D Lab
Growth & Milestones
Growth Metrics
100+ customers globally
Major Milestones
Founded in 2006; Strategic partnership with Hanwha Chemical (2010); Strategic partnership with POSCO (2011); Joint development agreement with Terrafilum for graphene-enhanced 3D printing filament; Acquired by NanoXplore (2022)
Notable Customers
Ford; Callaway Golf; HELLA; Terrafilum
Funding rounds
- Seed$1.8M2014Lead: Great Oaks Venture Capital · Source: WSJ